Memokath® 044TW Stent for Treatment of Urethral Stricture (NCT00270504) | Clinical Trial Compass
CompletedPhase 3
Memokath® 044TW Stent for Treatment of Urethral Stricture
United States92 participantsStarted 2002-12
Plain-language summary
The purpose of this study is to evaluate if the placement of a temporary urethral stent for up to 12 months, following dilation or internal urethrotomy (cutting open), results in a higher rate of urethral patency during the first year of follow-up when compared to the control group that does not receive a stent.
Who can participate
Age range21 Years
SexMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Males \> 21 years of age
✓. Recurrent stricture of the bulbar urethra:
✓. \< 50 mm in length on urethrography; and which
✓. has a segment unable to accommodate a 16Fr flexible cystoscope
✓. Healthy tissue on both sides of stent
✓. Urinary flow in the abnormal range of the Siroky nomogram.
✓. Written informed consent obtained prior to participation in the study
✓. Patients must be available for all follow-up visits.
Exclusion criteria
✕. Strictures:
✕. outside the bulbous urethra
✕. associated with, or suspected to be, urethral carcinoma
✕. secondary to pelvic distraction injuries
✕. Inability to enlarge the bulbar urethral stricture to \> 26 Fr.